Furthermore, in vivo administration of agonistic anti-CD137 monoclonal antibody to lupus mice reduces symptoms, strongly suggesting that CD137-CD137L is involved in immune regulation and tolerance [58] (Figure 1). Here, TNFSF9 is linked to systemic lupus erythematosus.